Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / ADR
-
Total 13F shares
-
229,318,256
-
Share change
-
+7,455,929
-
Total reported value
-
$9,881,828,420
-
Put/Call ratio
-
51%
-
Price per share
-
$43.12
-
Number of holders
-
768
-
Value change
-
+$323,644,299
-
Number of buys
-
325
-
Number of sells
-
320
Institutional Holders of GLAXOSMITHKLINE PLC - ADR (GSK) as of Q2 2017
As of 30 Jun 2017 GLAXOSMITHKLINE PLC - ADR (GSK) had 768 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 229,318,256 shares of stock of the company.
Largest 10 holders included FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, Fisher Asset Management, LLC, WELLS FARGO & COMPANY/MN, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, ROYAL BANK OF CANADA, HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC, BANK OF AMERICA CORP /DE/, and Bank of New York Mellon Corp.
This table shows 771 institutional shareholders of the security as of 30 Jun 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.